Inogen adds executive VP; co-founder Myers to step down

Inogen, a Goleta-based medical technology company that makes portable oxygen concentrators, announced April 7 that it has hired Georg Parr as executive vice president and chief commercial officer. Byron Myers, a member of Inogen’s founding team and the current executive vice president for marketing, will step down on June 4, as will Arron Retterer, the Read More →
Inogen announces net loss, predicts better 2021

Goleta-based Inogen reported declines in both revenue and net income due to the COVID-19 pandemic on Feb. 24, when the maker of portable oxygen concentrators released its financial results for the fourth quarter and full year of 2020. Total revenue for the fourth quarter was $74 million, a decline of 6.3% from the same quarter Read More →
Inogen names new CEO

Inogen, a medical device company in Goleta that makes portable oxygen concentrators, named a new president and CEO on Jan. 27. Nabil Shabshab, 56, will lead the company starting Feb. 8, Inogen said. He has spent the last nine years with the medical technology company Becton Dickinson and Company, including the past three and a Read More →
Inogen misses revenue target, reports loss

Inogen, a Goleta-based medical technology company that produces a portable oxygen concentrator, reported a net loss of $1.7 million and missed revenue estimates in its third quarter financial report. The company saw an almost 20% drop in total revenue from its position a year before, which it attributed to COVID-19. While the company’s rental revenue Read More →
Don’t touch and go: Allthenticate prepares offices and workers for safe returns

Businesses are searching for ways to reduce touchpoints in the wake of the coronavirus pandemic, and one Goleta cybersecurity firm has a touch-free technology that could answer the call. UC Santa Barbara startup Allthenticate has netted $500,000 in venture capital to fund the rollout of cell phone software and smart door readers that allows access Read More →
Inogen revenue falls, but Q2 earnings beat analyst estimates

The COVID-19 pandemic continued to cut into Inogen’s revenue, as new physician referrals and patient mobility declined during a quarter usually marked by increased patient travel and demand. Revenue fell nearly 30 percent in the second quarter to $71.7 million, missing average analyst estimates, and net income of $2.7 million was down from $9.9 million Read More →